» Articles » PMID: 16491423

The Presentation of Malignant Tumours and Pre-malignant Lesions Incidentally Found on PET-CT

Overview
Date 2006 Feb 24
PMID 16491423
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of the study was to determine the general and organ-specific presentation of incidental primary tumours on PET-CT.

Methods: PET-CT reports of 2,360 consecutive patients were reviewed and revealed 156 lesions suspicious for a new unexpected malignancy, in 151 patients. One hundred and twenty of these lesions, in 115 patients, were further assessed, by biopsy (n=84 patients) or by clinical and imaging follow-up (n=31 patients) for a mean of 17+/-4 months (range 12-25 months).

Results: Forty-four unexpected malignancies were found in 41 of the study patients (1.7%). Twenty-seven of the 44 incidental tumours were identified on the basis of their location, which was uncommon for metastasis of the known malignancy. Eight were detected as a result of either the difference in FDG avidity of the known malignancy and the incidental lesion or the presence of an incidental non-FDG-avid mass on the CT part of the study. Four tumours were synchronous carcinomas in patients with known colorectal malignancy, three were identified by virtue of the discordant response to treatment compared with the known primary tumour and two were detected as new sites of disease after a prolonged disease-free period. There was organ variability in the positive predictive values (PPV) of PET-CT findings for incidental primary malignancy or pre-malignant lesions: 62% for colonic lesions, 54% for lung lesions and 24% for thyroid lesions.

Conclusion: Incidental primary tumours may be identified on PET-CT based on their location, FDG avidity, response to therapy and time of appearance. The PET and CT parts of the study appear to complement each other and assist in identification of these incidental tumours.

Citing Articles

Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review.

Luo J, Bahlis N, Chan D, Duggan P, Jimenez-Zepeda V, Lee H Curr Oncol. 2024; 31(12):7445-7458.

PMID: 39727673 PMC: 11674242. DOI: 10.3390/curroncol31120550.


Returning Incidental Research Findings From F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography to Participants: A Survey of Investigators From a Clinical Trial of Rheumatoid Arthritis.

Kang J, Andrews H, Giles J, Liao K, Solomon D, Bathon J Arthritis Care Res (Hoboken). 2024; 76(12):1637-1646.

PMID: 39228043 PMC: 11633242. DOI: 10.1002/acr.25424.


The effect of butylscopolamine on [F]FDG uptake in the gastrointestinal tract is negligible and regionally variable.

Guhne F, Ndum F, Seifert P, Winkens T, Drescher R, Freesmeyer M EJNMMI Res. 2023; 13(1):61.

PMID: 37340145 PMC: 10281937. DOI: 10.1186/s13550-023-01012-2.


Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients.

Paran M, Shulman K, Kessel B, Dagan J Rambam Maimonides Med J. 2022; 13(2).

PMID: 35482458 PMC: 9049150. DOI: 10.5041/RMMJ.10472.


Incidental anal fluorodeoxyglucose uptake: Should we further examine the patient?.

Moussaddaq A, Brochard C, Palard-Novello X, Garin E, Wallenhorst T, Le Balch E World J Clin Cases. 2020; 8(17):3679-3690.

PMID: 32953844 PMC: 7479548. DOI: 10.12998/wjcc.v8.i17.3679.


References
1.
Levine M, Rubesin S, Laufer I, Herlinger H . Diagnosis of colorectal neoplasms at double-contrast barium enema examination. Radiology. 2000; 216(1):11-8. DOI: 10.1148/radiology.216.1.r00jl3311. View

2.
Gutzeit A, Antoch G, Kuhl H, Egelhof T, Fischer M, Hauth E . Unknown primary tumors: detection with dual-modality PET/CT--initial experience. Radiology. 2004; 234(1):227-34. DOI: 10.1148/radiol.2341031554. View

3.
Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, OMorain C, Kronborg O . Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004; 47(3):323-33. DOI: 10.1007/s10350-003-0054-1. View

4.
Lardinois D, Weder W, Hany T, Kamel E, Korom S, Seifert B . Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003; 348(25):2500-7. DOI: 10.1056/NEJMoa022136. View

5.
Agress Jr H, Cooper B . Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2003; 230(2):417-22. DOI: 10.1148/radiol.2302021685. View